Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,121 | -79,279 | -46,508 | N/A | -7,272 |
| Depreciation Amortization | 528 | 25,761 | 986 | N/A | 280 |
| Income taxes - deferred | -793 | -2,097 | -2,651 | N/A | N/A |
| Accounts receivable | 110 | 1,049 | 198 | N/A | 405 |
| Other Working Capital | 1,681 | 31,814 | 2,920 | N/A | -1,850 |
| Other Operating Activity | 19,111 | 4,458 | 8,142 | 0 | 727 |
| Operating Cash Flow | $-82,484 | $-18,294 | $-36,913 | $N/A | $-7,710 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 54,112 | -164,780 | 22,764 | N/A | N/A |
| PPE Investments | -12,749 | -54,079 | -1,072 | N/A | -266 |
| Net Acquisitions | N/A | N/A | 2,699 | N/A | N/A |
| Other Investing Activity | -135 | -72 | -18 | 0 | -18 |
| Investing Cash Flow | $41,228 | $-218,931 | $24,373 | $N/A | $-284 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,357 | 289,433 | 918 | N/A | 56 |
| Other Financing Activity | -52 | -48 | -133 | 0 | 0 |
| Financing Cash Flow | $10,305 | $289,385 | $785 | $N/A | $56 |
| Beginning Cash Position | 61,580 | 9,420 | 21,175 | N/A | 64,010 |
| End Cash Position | 30,629 | 61,580 | 9,420 | N/A | 56,072 |
| Net Cash Flow | $-30,951 | $52,160 | $-11,755 | $N/A | $-7,938 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,484 | -18,294 | -36,913 | N/A | -7,710 |
| Capital Expenditure | -12,749 | -54,414 | -1,072 | N/A | -266 |
| Free Cash Flow | -95,233 | -72,708 | -37,985 | 0 | -7,976 |